Clinuvel Pharmaceuticals Ltd
F:UR9
Clinuvel Pharmaceuticals Ltd
F:UR9
Price:
5.41
EUR
0.19%
Market Closed
Market Cap:
€267.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Clinuvel Pharmaceuticals Ltd
F:UR9
|
AU |
|
F
|
Fluidigm Corp
F:FLB
|
US |
|
Viscofan SA
MAD:VIS
|
ES |
|
C
|
China Citic Bank Corp Ltd
XBER:D7C
|
CN |
|
Soditech SA
PAR:SEC
|
FR |
|
B
|
BBMG Corp
SWB:9BM
|
CN |
|
R
|
Ryman Healthcare Ltd
SWB:RH7
|
NZ |
|
Metals X Ltd
ASX:MLX
|
AU |
|
OneMain Holdings Inc
F:0S1
|
US |
|
E
|
Eventbrite Inc
SWB:EB4
|
US |
|
I
|
Ipsen SA
OTC:IPSEF
|
FR |
|
B
|
BBMG Corp
XMUN:9BM
|
CN |
|
E
|
EVN AG
DUS:EVN
|
AT |
|
T
|
TFI International Inc
F:9TF
|
CA |
|
D
|
DSV A/S
XMUN:DS81
|
DK |
|
P
|
Petrofac Ltd
F:P2F
|
JE |
|
D
|
Dover Corp
DUS:DOV
|
US |
|
W
|
Websol Energy System Ltd
BSE:517498
|
IN |
|
Dwarikesh Sugar Industries Ltd
BSE:532610
|
IN |
Multiples-Based Value
The Multiples-Based Value for 
Clinuvel Pharmaceuticals Ltd (UR9) under the Base Case is hidden
EUR.
Compared with the current market price of 5.41 EUR, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
UR9 Multiples-Based Value
LOCKED
